<unk>  is considered an epidemic worldwide. It continues to be one of the most common diseases. In October 2013, CDC data from the 2011-2012 National Health And Nutrition Examination Survey (NHANES) demonstrated that the overall age-adjusted prevalence of<unk>  among U.S. adults aged 18 and older was 29.1%. Similar surveys conducted in Europe estimated the prevalence of<unk>  to be 44%. The prevalence of<unk>  increases among older patients and among non-Hispanic black patients, but is similar in both genders.
Chronic hypertension epidemiology and demographics
Atherosclerosis epidemiology and demographics
Metabolic syndrome epidemiology and demographics
Ventricular fibrillation epidemiology and demographics
Peripheral arterial disease epidemiology and demographics
Diabetic nephropathy epidemiology and demographics
Hypertensive nephropathy epidemiology and demographics
High density lipoprotein epidemiology and demographics